Zobrazeno 1 - 10
of 269
pro vyhledávání: '"Angel M, Cronin"'
Autor:
David D. Yang, Daniela L. Buscariollo, Angel M. Cronin, Shicheng Weng, Melissa E. Hughes, Richard J. Bleicher, Adam L. Cohen, Sara H. Javid, Stephen B. Edge, Beverly Moy, Joyce C. Niland, Antonio C. Wolff, Michael J. Hassett, Rinaa S. Punglia
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-7 (2020)
Abstract Background Although the 21-gene recurrence score (RS) assay is widely used to predict distant recurrence risk and benefit from adjuvant chemotherapy among women with hormone receptor-positive (HR+) breast cancer, the relationship between the
Externí odkaz:
https://doaj.org/article/d4bb13507ca44041af2782a5fdc08c31
Autor:
Hans Lilja, Henrik Grönberg, Andrew J. Vickers, Kenneth Offit, Peter T. Scardino, Jianfeng Xu, Pär Stattin, Anders S. Bjartell, Fredrik Wiklund, Alexander Ploner, Angel M. Cronin, Christer Halldén, Robert J. Klein
Supplementary Tables 1-6 from Blood Biomarker Levels to Aid Discovery of Cancer-Related Single-Nucleotide Polymorphisms: Kallikreins and Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5bf4bfbca71b927c577f7a6f2307d47
https://doi.org/10.1158/1940-6207.22524738
https://doi.org/10.1158/1940-6207.22524738
Autor:
Oreofe O. Odejide, Ling Li, Angel M. Cronin, Anays Murillo, Paul G. Richardson, Kenneth C. Anderson, Gregory A. Abel
Publikováno v:
Haematologica, Vol 103, Iss 8 (2018)
Patients with advanced myeloma experience a high symptom burden particularly near the end of life, making timely hospice use crucial. Little is known about the quality and determinants of end-of-life care for this population, including whether potent
Externí odkaz:
https://doaj.org/article/9a8bb354b1d245ed87b6a0b851c8a429
Autor:
Sarah C Markt, Tianyu Tang, Angel M Cronin, Ingrid T Katz, Brooke E Howitt, Neil S Horowitz, Larissa J Lee, Alexi A Wright
Publikováno v:
PLoS ONE, Vol 13, Iss 2, p e0193047 (2018)
Cervical cancer outcomes remain poor among disadvantaged populations, including ethnic minorities, low-income, and underinsured women. The aim of this study was to evaluate the mechanisms that underlie the observed association between race/ethnicity
Externí odkaz:
https://doaj.org/article/676532baaa3c4a6ab3efa86f511c1c0a
Autor:
Deborah Schrag, Michael Milligan, Debra Nana Yeboa, Yolonda L. Colson, Angel M. Cronin, Aileen B. Chen, Kenneth L. Kehl
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:547-554
Background: Among patients diagnosed with stage IA non–small cell lung cancer (NSCLC), the incidence of occult brain metastasis is low, and several professional societies recommend against brain imaging for staging purposes. The goal of this study
Autor:
Jill O. Robinson, Barbara B. Biesecker, Ragan Hart, Amy L. McGuire, Stacy W. Gray, Wendy K. Chung, Barbara A. Bernhardt, Ida Griesemer, Julia Wynn, Kurt D. Christensen, Leslie G. Biesecker, Christine Rini, Donald L. Patrick, Robert C. Green, Angel M. Cronin, David L. Veenstra
Publikováno v:
Genet Med
PURPOSE: As exome and genome sequencing (ES, GS) enters the clinic, there is an urgent need to understand the psychological effects of test result disclosure. Through a Clinical Sequencing Exploratory Research (CSER), phase 1 (CSER1) consortium colla
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:1367-1371
Background: Women with a history of ductal carcinoma in situ (DCIS) are at increased risk for developing a second breast cancer (SBC). A prior meta-analysis of randomized studies of radiotherapy (RT) for DCIS has shown a trend toward increased breast
Autor:
Stacy W. Gray, Jenny Shen, Sam E. Wing, Katherine Hicks-Courant, Angel M. Cronin, Ernesto Sosa, Elizabeth F. Bair, Rebekah H. Nagler, Angela Stroupe
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 741, p 741 (2021)
Journal of Personalized Medicine
Volume 11
Issue 8
Journal of Personalized Medicine
Volume 11
Issue 8
Background: Given that media coverage can shape healthcare expectations, it is essential that we understand how the media frames “personalized medicine” (PM) in oncology, and whether information about unproven technologies is widely disseminated.
Autor:
Mark C. Hornbrook, Matthew P. Banegas, Debra P. Ritzwoller, Maureen C. O'Keeffe Rosetti, Nikki M. Carroll, Shicheng Weng, Angel M. Cronin, Michael J. Hassett, Hajime Uno
Publikováno v:
Journal of Oncology Practice. 15:e616-e627
PURPOSE: Spending for patients with advanced cancer is substantial. Past efforts to characterize this spending usually have not included patients with recurrence (who may differ from those with de novo stage IV disease) or described which services dr
Autor:
Jennifer W. Mack, James A. Tulsky, Gregory A. Abel, Craig C. Earle, Angel M. Cronin, Anand R. Habib, Oreofe O. Odejide
Publikováno v:
J Palliat Med
Background: Although blood cancers are accompanied by a high level of prognostic uncertainty, little is known about when and how hematologic oncologists discuss prognosis. Objectives: Characterize reported practices and predictors of prognostic discu